Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
NCT02429557 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2026-05-05
Summary
Compression garments have been shown to be effective in the treatment of orthostatic hypotension in autonomic failure patients. The purpose of this study is to determine the hemodynamic mechanisms by which abdominal compression (up to 40 mm Hg) improve the standing blood pressure and orthostatic tolerance in these patients, and to compare them with those of the standard of care midodrine. The investigators will test the hypothesis that abdominal compression will blunt the exaggerated fall in stroke volume and the increase in abdominal vascular volume during head up tilt.
Conditions
- Orthostatic Hypotension
- Pure Autonomic Failure
- Multiple System Atrophy
- Autonomic Failure
Interventions
- DRUG
-
midodrine
Midodrine single dose 2.5-10mg PO given 1 hour before the second head up tilt
- OTHER
-
Abdominal compression
Abdominal compression of 40 mmHg with a commercial inflatable cuff applied during head up tilt
- OTHER
-
Sham abdominal compression
Sham abdominal compression of 5 mmHg with a commercial inflatable cuff applied during head up tilt
- DRUG
-
Placebo pill
Placebo pill given 1 hour before the second heat up tilt
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
Vanderbilt University Medical Center
lead OTHER
Principal Investigators
-
Italo Biaggioni, MD · Vanderbilt University
-
Luis E Okamoto, MD · Vanderbilt University Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- United States
Study Locations
More Related Trials
-
Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension
NCT00555880 ·Status: COMPLETED ·Phase: PHASE4
-
Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic
NCT02726711 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension
NCT00004268 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Norepinephrine for Orthostatic Hypotension
NCT01285908 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension
NCT02425566 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study
NCT02308124 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Subjects With Neurogenic Orthostatic Hypotension
NCT07089043 ·Status: RECRUITING ·Phase: PHASE2
-
The Role of Endothelin in the Supine Hypertension of Autonomic Failure
NCT01119417 ·Status: WITHDRAWN ·Phase: PHASE1
-
Autonomic Nervous System and Nitric Oxide Interactions
NCT01137253 ·Status: COMPLETED ·Phase: PHASE1
-
Autonomic Determinants of POTS - Pilot 2
NCT04140721 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Midodrine for the Early Liberation of Vasopressor Support in the ICU
NCT04489589 ·Status: COMPLETED ·Phase: PHASE4
-
Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist
NCT03070730 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Pathophysiology of Orthostatic Intolerance
NCT00608725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)
NCT01000350 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical Autonomic Disorders: A Training Protocol
NCT02154009 ·Status: TERMINATED
-
Water and Sudafed in Autonomic Failure
NCT02149901 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Water and the Gastropressor Response - Tachyphylaxis
NCT00580996 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Influence of the Autonomic Nervous System in Response to Exercise in Hypertensive Individuals
NCT04371757 ·Status: UNKNOWN ·Phase: NA
-
Nitric Oxide and the Autonomic Nervous System
NCT00178919 ·Status: COMPLETED ·Phase: NA
-
POTS NET mRNA Functional Correlation With NET Activity
NCT03218761 ·Status: ACTIVE_NOT_RECRUITING
-
Non-Pharmacologic Therapy for Neurocardiogenic Syncope
NCT00096902 ·Status: COMPLETED ·Phase: PHASE2
-
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
NCT05267886 ·Status: RECRUITING ·Phase: PHASE4
-
Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV
NCT01456481 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
: Vascular Function in Health and Disease
NCT02966665 ·Status: RECRUITING ·Phase: PHASE1
-
Nebivolol in the Supine Hypertension of Autonomic Failure
NCT01044693 ·Status: COMPLETED ·Phase: NA